SCHEMBL15047822

SCHEMBL15047822

COc1ccc2[nH]cc(CCNC(=O)c3ccc(O)cc3O)c2c1

nearest known ligand 0.80

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGS1 P23219 3/20 0.71
KMT2A Q03164 2/20 0.70
POLB P06746 1/20 0.70
MTNR1A P48039 8/20 0.69
MTNR1B P49286 5/20 0.67
KDM4E B2RXH2 1/20 0.67
MEN1 O00255 1/20 0.67
ALDH1A1 P00352 1/20 0.67
CYP1A1 P04798 1/20 0.67
MPO P05164 1/20 0.67
CYP1A2 P05177 1/20 0.67
CYP3A4 P08684 1/20 0.67
HTR1A P08908 1/20 0.67
CYP2D6 P10635 1/20 0.67
HPGD P15428 1/20 0.67
NQO2 P16083 1/20 0.67
HTR2B P41595 1/20 0.67
RAB9A P51151 1/20 0.67
BLM P54132 1/20 0.67
PMP22 Q01453 1/20 0.67

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31177165 0.91 PTGS2 (0.74) PTGS1KMT2APOLBMTNR1AMTNR1B
SCHEMBL803841 0.89 PTGS1 (0.84) PTGS1KMT2AKDM4EMEN1ALDH1A1
SCHEMBL28403541 0.83 PTGS1 (1.00) PTGS1KMT2APOLBMEN1CYP1A2
SCHEMBL31177161 0.83 PTGS2 (0.72) PTGS1KMT2APOLBMTNR1AMTNR1B
SCHEMBL798092 0.83 KMT2A (0.80) KMT2APOLBMTNR1AMTNR1BKDM4E
SCHEMBL803617 0.82 PTGS1 (0.82) PTGS1KMT2AKDM4EMEN1ALDH1A1
SCHEMBL15145393 0.82 PTGS1 (0.74) PTGS1KMT2AMTNR1AMTNR1BKDM4E
SCHEMBL28638373 0.82 KMT2A (0.67) PTGS1KMT2APOLBMTNR1AMTNR1B
SCHEMBL28408669 0.81 PTGS1 (0.74) PTGS1KMT2APOLBMTNR1AMTNR1B
SCHEMBL28638912 0.81 PTGS2 (0.74) PTGS1KMT2APOLBMTNR1AMTNR1B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2790659-B1 COSMETIC COMPOSITION FOR STIMULATING THE CELLULAR ANTI-AGING FUNCTIONS OF THE SKIN SYNTIVIA (FR) 2017-03-01 EP disclosed
US-20150031740-A1 COSMETIC COMPOSITION FOR STIMULATING THE CELLULAR ANTI-AGING FUNCTIONS OF THE SKIN UNIVERSITE PAUL SABATIER TOULOUSE III (FR) 2015-01-29 US disclosed
US-20150031740-A1 COSMETIC COMPOSITION FOR STIMULATING THE CELLULAR ANTI-AGING FUNCTIONS OF THE SKIN UNIVERSITE PAUL SABATIER TOULOUSE III (FR) 2015-01-29 US disclosed
WO-2013087834-A2 COSMETIC COMPOSITION FOR STIMULATING THE CELLULAR ANTI-AGING FUNCTIONS OF THE SKIN SYNTIVIA (FR) 2013-06-20 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150031740-A1 COSMETIC COMPOSITION FOR STIMULATING THE CELLULAR ANTI-AGING FUNCTIONS OF THE SKIN H1-0, C1R, H1-3 PTGS1 858/4885KMT2A 3404/4885POLB 329/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.